| The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling. Curtis C.D., Griffin C.T.
Mol. Cell. Biol. 32:1312-1320(2012) · Mapped (31) |
| The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Griffin C.T., Curtis C.D., Davis R.B., Muthukumar V., Magnuson T.
Proc. Natl. Acad. Sci. U.S.A. 108:2282-2287(2011) · Mapped (16) |
| Long-range transcriptional control of progesterone receptor gene expression. Boney-Montoya J., Ziegler Y.S., Curtis C.D., Montoya J.A., Nardulli A.M.
Mol. Endocrinol. 24:346-358(2010) · Mapped (68) |
| Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression. Curtis C.D., Thorngren D.L., Ziegler Y.S., Sarkeshik A., Yates J.R., Nardulli A.M.
Mol. Endocrinol. 23:1346-1359(2009) · Mapped (2) |
| Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Curtis C.D., Likhite V.S., McLeod I.X., Yates J.R., Nardulli A.M.
Cancer Res. 67:10600-10607(2007) · Mapped (59) |
